Zhuzhou Qianjin Pharmaceutical Co., Ltd. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Zhuzhou Qianjin Pharmaceutical Co., Ltd. with three other
companies in this sector in China:
Jinling Pharmaceutical Company Limited
sales of 3.19 billion Chinese Renmimbi [US$464.19 million]
of which 68%
was Medicine Manufacture),
Guangdong Taiantang Pharmaceutical Co Ltd
(3.23 billion Chinese Renmimbi [US$470.29 million]
of which 49%
was Medicine Wholesale & Retail), and
Heilongjiang ZBD Pharmaceutical Co Ltd
(3.14 billion Chinese Renmimbi [US$456.78 million]
of which 62%
was Pharmaceutical Industry).
During the year ended December of 2017, sales at
Zhuzhou Qianjin Pharmaceutical Co., Ltd. were 3.18 billion Chinese Renmimbi (US$462.80 million).
increase of 11.1%
versus 2016, when the company's sales were 2.86 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Zhuzhou Qianjin Pharmaceutical Co., Ltd.
(and since 2012, sales have increased a total of 101%).
Sales of Other saw an increase
18.5% in 2017, from
217.67 million Chinese Renmimbi to 257.97 million Chinese Renmimbi.